The Commission accepts than Aventis as a whole is a much larger company than Merck. However, for the purpose of this Decision, the addressee is not Aventis SA, but its subsidiaries Aventis Pharma SA and Rhône-Poulenc Biochimie SA. The Commission further notes that both these companies are smaller than Merck.
Recital 244, Decision_act (EU) 2004/104
In forcesince 27 Nov 2002